NFE2L2 and cancer: While nucleotide synthesis can support cancer cell proliferation, recent work has also shown that NRF2 signaling promotes transcriptional and metabolic reprogramming to support redox homeostasis and increase de novo nucleotide synthesis during breast tumor recurrence [36].